Gaurav Shah - 18 Aug 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
18 Aug 2025
Net transactions value
-$6,814
Form type
4
Filing time
20 Aug 2025, 17:00:17 UTC
Previous filing
22 May 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shah Gaurav CEO, Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah 20 Aug 2025 0001725922

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Tax liability $6,814 -2,234 -0.28% $3.05 784,572 18 Aug 2025 Direct F1, F2
holding RCKT Common Stock 207,897 18 Aug 2025 By Spouse
holding RCKT Common Stock 198,341 18 Aug 2025 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were withheld by the Company in order to pay tax withholding obligations in connection with the vesting of RSUs.